Increased expression of p300 has also been reported to correlate with poor survival and aggressive phenotypes in HCC, and p300 inhibitor attenuates HCC through epigenetic regulation of glycolytic function and nucleotide synthesis (Cai et al., 2021). This evidence concerns the gene EP300 and hepatocellular carcinoma.